Fierce Pharma

JANUARY 5, 2024

Three days after the FDA included Novo Nordisk’s semaglutide treatments Ozempic and Wegovy on a list of medicines that it would monitor for side effects—one of them suicide ideation—a study of medi | Three days after the FDA included Novo Nordisk’s semaglutide treatments Ozempic and Wegovy on a list of medicines that it would monitor for side effects—one of them suicide ideation—a study of medical records of patients shows no link between use of the GLP-1 drugs and an increase in suicidal though

Side effects 325

Side effects Medicine FDA Medical 325

MedCity News

JANUARY 5, 2024

A bipartisan group of senators sent a letter to HHS asking it to rethink its appeal of a recent federal district court decision that limits the use of “copay accumulators” — which are programs insurers use to prevent medication copay assistance from counting toward patients’ deductibles or out-of-pocket maximums.

Insurance 135

Insurance Medical Patients Pharma 135

Fierce Pharma

JANUARY 5, 2024

When Theravance called it quits on a phase 2 JAK inhibitor program last February, the South San Francisco and Dublin-based biopharma company put the majority of its chips on a head-to-head trial pi | In the phase 4 study, Theravance and Viatris’ Yupelri failed to demonstrate greater lung function improvement in adults with COPD versus Spiriva delivered by a dry powder inhaler, Theravance said Friday.

Biopharma 263

Biopharma 263

MedCity News

JANUARY 5, 2024

As we look into the future, 2024 promises a profound transformation. Here are five areas of focus for the upcoming year.

Healthcare 130

Healthcare Healthcare 130

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 5, 2024

The last few days of 2023 and the beginning of 2024 featured a flurry of dealmaking by the likes of AstraZeneca, Johnson & Johnson, Roche and Boehringer Ingelheim with Asian companies | A flurry of deals were inked by the likes of AstraZeneca, Johnson & Johnson, Roche and Boehringer Ingelheim with Asian companies. Big Pharma companies are also increasingly entrusting commercialization of some products in China to domestic firms.

Pharma 243

Pharma 243

MedCity News

JANUARY 5, 2024

Check out news from Kismet Health, the University of California at Berkeley’s life science startups, and the companies presenting at the Consumer Technology Association’s pitch contest at CES.

Healthcare 124

Healthcare Healthcare 124

MedCity News

JANUARY 5, 2024

Solera Health has added virtual specialty care services to its Halo Platform. The new offering is in partnership with 9amHealth, Vori Health and Oshi Health.

123

123

Pharmaceutical Technology

JANUARY 5, 2024

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

Biopharma 122

Biopharma 122

MedCity News

JANUARY 5, 2024

Crowded EDs will continue to plague the healthcare ecosystem and prevent the efficient delivery of care if the structure and education of care, resources, and availability are kept the same. UC can step in with its well-equipped and trained staff so that EDs can focus on what they do best, care for life-threatening situations.

Education 119

Education Training Healthcare Healthcare 119

European Pharmaceutical Review

JANUARY 5, 2024

Under a new licensing agreement, Stemline Therapeutics, Inc., a wholly-owned subsidiary of the Menarini Group, gains the global rights to develop and commercialise a novel, small molecule KAT6A inhibitor. This treatment has potential for hormone sensitive cancers such as breast cancer, and other oncology indications. The therapeutic is designed using the artificial intelligence (AI)-platform from Insilico Medicine, the biotech company that is also part of this collaboration.

Medicine 115

Medicine Biopharma Patients Pharmaceutical 115

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 5, 2024

In predicting that the Medi-Cal coverage protections during the pandemic would end, advocates successfully pushed for California to adopt a continuous Medi-Cal coverage policy for children ages 0-5 – avoiding annual renewals during this vulnerable time in their childhood development. For this important protection to become a reality as soon as possible, we now need the Governor to fund and greenlight this policy immediately–in his January 2024 Budget proposal.

115

115

European Pharmaceutical Review

JANUARY 5, 2024

Utilising an add-on therapy for treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals SPA has reported significant final, one-year results from its clinical trial 014/015, evaluating evenamide as an add-on therapy to antipsychotics in treatment-resistant schizophrenia (TRS). Evenamide According to Newron, evenamide is an orally available new chemical entity that normalises glutamate release induced by aberrant sodium channel activity (veratridine-stimulated).

Food and Drug Administration 111

Food and Drug Administration Medical Safety Patients 111

PharmaVoice

JANUARY 5, 2024

Although three companies dominate the space, emerging infectious disease focus areas and a handful of other key players are augmenting the market.

Marketing 105

Marketing 105

Pharmaceutical Commerce

JANUARY 5, 2024

LillyDirect will facilitate access to medications by connecting patients with independent telehealth providers, bypassing the need to obtain a prescription from a physician and then going to a pharmacy to fill it.

Prescription 105

Prescription Physicians Medical Patients 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JANUARY 5, 2024

Beckley Psytech has announced that is has received substantial strategic investment from atai Life Sciences, totalling $50 million, to accelerate the clinical development of short-duration psychedelics.

97

97

PharmaTimes

JANUARY 5, 2024

Vd1-gd T cells were effective in predicting positive responses to ICI therapy

Patients 96

Patients 96

PharmExec

JANUARY 5, 2024

The LillyDirect platform will allow patients who are prescribed the popular weight loss drug Zepbound to obtain the drug via Lilly’s at-home prescription delivery service.

Prescription 74

Prescription Patients 74

PharmaTimes

JANUARY 5, 2024

The companies will aim to select targets, discover and develop new therapeutics

96

96

Advertisement

Healthcare Success

JANUARY 5, 2024

Managing a PPC strategy for any sized business is complex and challenging. But organizations with dozens or hundreds of locations face even more hurdles: Multilocation providers must consider each location’s unique needs, competitive situation, and business objectives—compounding the complexity of managing an accurate and effective PPC (aka pay-per-click or paid search) strategy.

Healthcare 73

Healthcare Healthcare Management Marketing 73

Pharmaceutical Technology

JANUARY 5, 2024

Intellia Therapeutics announced its clinical goals for the next few years, pushing development for its late-stage ATTR asset.

64

64

Pharmacy Times

JANUARY 5, 2024

Investigators optimized the assay during development and qualification to be used in the clinical setting for pneumococcal conjugate vaccines.

55

55

Pharmaceutical Technology

JANUARY 5, 2024

A BBC team was able to buy over 1600 prescription pills by supplying fake data, raising concerns over limited oversight.

Prescription 59

Prescription Media 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

JANUARY 5, 2024

Findings may translate to a safe intervention for older women at risk of osteoporosis.

52

52

Clarify Health

JANUARY 5, 2024

Welcome to our new podcast, Healthcare Unbound , where healthcare leaders and changemakers discuss ways to advance healthcare outcomes, costs, and affordability. Healthcare Unbound offers listeners a front-row seat to some of the brightest minds working to find solutions to the immense challenges we are facing in every corner of the industry. The podcast is the namesake of the Healthcare Unbound Summit we held in May 2022, where a select group of 150 industry thought leaders, innovators, and

Healthcare 52

Healthcare Healthcare Physicians Healthcare Provider 52

Pharmacy Times

JANUARY 5, 2024

In-hospital mortality and the Medicare Bundled Payments for Care Improvement (BPCI) model are not associated with changes in odds for Black individuals or female individuals.

52

52

Pharmaceutical Technology

JANUARY 5, 2024

The company aims to drive a small molecule resurgence with its lead Alzheimer’s symptom relief agent AD-101.

Leads 52

Leads 52

Advertisement

Distribution

Pharmacy Times

JANUARY 5, 2024

Although machine learning models demonstrate potential to improve early detection of Alzheimer disease, sample sizes that underrepresent ethnic and racial groups result in unfairness.

52

52

Pharmaceutical Commerce

JANUARY 5, 2024

Trials will evaluate four novel agents for cancers that include essential thrombocythemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, non-small cell lung cancer, endometrial carcinoma, and metastatic castration-resistant prostate cancer.

52

52

PharmExec

JANUARY 5, 2024

Proposed acquisition would have given IQVIA a market-leading position in healthcare advertising.

Media 52

Media Healthcare Healthcare Leads 52

Pharmaceutical Commerce

JANUARY 5, 2024

In the midst of being approved for commercial manufacturing of Pluvict, the 70,000 square-foot site was built specifically to accommodate RLT production.

Manufacturing 52

Manufacturing 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales